Healthcare provider profile · identity verified

Timothy J. Poate, MD

Internal Medicine · GREENWOOD VILLAGE, CO · NPI 1093865438

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	674	198
Levothyroxine Sodium	Levothyroxine Sodium	604	165
Losartan Potassium	Losartan Potassium	487	141
Atorvastatin Calcium	Atorvastatin Calcium	442	134
Amlodipine Besylate	Amlodipine Besylate	411	117
Tamsulosin Hcl	Tamsulosin Hcl	275	80
Lisinopril	Lisinopril	240	73
Trazodone Hcl	Trazodone Hcl	234	67
Eliquis	Apixaban	213	49
Omeprazole	Omeprazole	206	69
Allopurinol	Allopurinol	202	56
Simvastatin	Simvastatin	174	47
Metformin Hcl	Metformin Hcl	173	53
Sertraline Hcl	Sertraline Hcl	167	47
Zolpidem Tartrate	Zolpidem Tartrate	163	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	158	38
Duloxetine Hcl	Duloxetine Hcl	153	34
Hydrochlorothiazide	Hydrochlorothiazide	133	40
Finasteride	Finasteride	129	38
Pantoprazole Sodium	Pantoprazole Sodium	126	42
Escitalopram Oxalate	Escitalopram Oxalate	123	34
Metoprolol Succinate	Metoprolol Succinate	121	35
Meloxicam	Meloxicam	119	47
Gabapentin	Gabapentin	102	28
Synthroid	Levothyroxine Sodium	94	27
Furosemide	Furosemide	92	30
Tramadol Hcl	Tramadol Hcl	92	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	87	24
Lorazepam	Lorazepam	83	16
Clopidogrel	Clopidogrel Bisulfate	81	21
Alendronate Sodium	Alendronate Sodium	78	27
Mounjaro	Tirzepatide	73	suppressed
Potassium Chloride	Potassium Chloride	69	23
Azithromycin	Azithromycin	68	57
Valsartan	Valsartan	64	17
Clonazepam	Clonazepam	61	suppressed
Famotidine	Famotidine	60	19
Glipizide Er	Glipizide	58	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	46
Sodium Chloride	0.9 % Sodium Chloride	55	suppressed
Xarelto	Rivaroxaban	55	15
Albuterol Sulfate Hfa	Albuterol Sulfate	54	23
Alfuzosin Hcl Er	Alfuzosin Hcl	54	13
Tizanidine Hcl	Tizanidine Hcl	51	21
Heparin Sodium	Heparin Sodium,porcine	50	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	50	17
Potassium Chloride-0.9% Nacl	Potassium Chloride In 0.9%nacl	50	suppressed
Spironolactone	Spironolactone	50	16
Bupropion Xl	Bupropion Hcl	49	14
Jardiance	Empagliflozin	49	14
Metformin Hcl Er	Metformin Hcl	49	14
Carvedilol	Carvedilol	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	14
Ozempic	Semaglutide	46	suppressed
Ezetimibe	Ezetimibe	44	13
Alprazolam	Alprazolam	43	19
Chlorthalidone	Chlorthalidone	43	11
Celecoxib	Celecoxib	41	14
Pregabalin	Pregabalin	40	17
Vitamin D2	Ergocalciferol (Vitamin D2)	40	13
Methylprednisolone	Methylprednisolone	38	31
Montelukast Sodium	Montelukast Sodium	38	11
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Rivastigmine	Rivastigmine	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Atenolol	Atenolol	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Estradiol	Estradiol	30	14
Glipizide	Glipizide	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	21
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	13
Irbesartan	Irbesartan	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Acyclovir	Acyclovir	25	suppressed
Creon	Lipase/Protease/Amylase	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Mirtazapine	Mirtazapine	24	11
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Zaleplon	Zaleplon	23	suppressed
Ramipril	Ramipril	22	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	16
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Myrbetriq	Mirabegron	21	suppressed
Prednisone	Prednisone	21	11
Testosterone	Testosterone	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Ketoconazole	Ketoconazole	18	13
Lovastatin	Lovastatin	18	suppressed
Nystatin	Nystatin	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Cephalexin	Cephalexin	16	16
Clonidine Hcl	Clonidine Hcl	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Diazepam	Diazepam	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Acebutolol Hcl	Acebutolol Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Migergot	Ergotamine Tartrate/Caffeine	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error